Insight Molecular Diagnostics Inc.
IMDX
$5.34
-$0.18-3.17%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 455.81% | 162.39% | 456.27% | -8.44% | -76.36% |
| Total Receivables | 23.44% | 502.35% | 2,098.76% | 233.26% | -88.89% |
| Inventory | 103.02% | -- | -- | -- | -- |
| Prepaid Expenses | 97.61% | 126.89% | 68.03% | 27.68% | -6.70% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 101.38% | -- | -- | 100.72% | 160.43% |
| Total Current Assets | 346.25% | 169.28% | 454.90% | 9.92% | -71.67% |
|
|
|||||
| Total Current Assets | 346.25% | 169.28% | 454.90% | 9.92% | -71.67% |
| Net Property, Plant & Equipment | -0.12% | 12.38% | 24.93% | 16.34% | 11.35% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -74.17% | -74.18% | -74.19% | -74.19% | -0.16% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -39.10% | 6.14% | 9.54% | 10.54% | 8.06% |
| Total Assets | -37.43% | -32.39% | -14.95% | -53.16% | -13.94% |
|
|
|||||
| Total Accounts Payable | 21.10% | 21.50% | 150.99% | 139.14% | -23.24% |
| Total Accrued Expenses | -1.42% | 12.20% | 29.95% | 7.96% | 9.36% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 24.55% | 49.66% | 71.01% | 94.74% | 78.19% |
| Total Finance Division Other Current Liabilities | -63.93% | -70.22% | -81.29% | -90.33% | 16.51% |
| Total Other Current Liabilities | -63.93% | -70.22% | -81.29% | -90.33% | 16.51% |
| Total Current Liabilities | -15.73% | -7.59% | 16.28% | 1.13% | 13.16% |
|
|
|||||
| Total Current Liabilities | -15.73% | -7.59% | 16.28% | 1.13% | 13.16% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -43.54% | -30.48% | -17.50% | 7.49% | 15.04% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -9.78% | -2.96% | -11.17% | -5.49% | 69.62% |
| Total Liabilities | -12.18% | -4.99% | -7.24% | -3.94% | 54.74% |
|
|
|||||
| Common Stock & APIC | 12.81% | 12.80% | 18.30% | 9.01% | 5.38% |
| Retained Earnings | -19.17% | -20.89% | -19.47% | -20.93% | -16.36% |
| Treasury Stock & Other | 50.88% | 129.73% | 2.50% | -57.14% | 78.13% |
| Total Common Equity | -194.70% | -95.16% | -11.82% | -159.97% | -74.15% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -194.70% | -95.16% | -11.82% | -159.97% | -74.15% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -194.70% | -95.16% | -39.61% | -147.96% | -77.14% |
|
|
|||||